Hyoscyamine, its salts and derivatives
Hyoscyamine, its salts and derivatives is listed in Annex II as a prohibited substance for cosmetic products placed on the EU market.
Chemical identity and properties

Benzeneacetic acid, alpha-(hydroxymethyl)-, (3-endo)-8-methyl-8-azabicyclo(3.2.1)oct-3-yl ester, (alphaS)-
(S)-atropine is an atropine with a 2S-configuration. It is functionally related to a (S)-tropic acid. It is a conjugate base of a (S)-atropinium. — ChEBI
- IUPAC name
- [(1R,5S)-8-methyl-8-azabicyclo[3.2.1]octan-3-yl] (2S)-3-hydroxy-2-phenylpropanoate
- Molecular formula
- C17H23NO3
- Molecular weight
- 289.4 g/mol
- Exact mass
- 289.16779360 Da
- XLogP3
- 1.8
- Topological polar surface area
- 49.8 Ų
- Hydrogen-bond donors
- 1
- Hydrogen-bond acceptors
- 4
- Covalent units
- 1
- Defined stereocentres
- 3
Also known as
16 more reported names
External database identifiers
- ChEBI:CHEBI:17486
- ChEBI:CHEBI:92712
- ChEMBL:CHEMBL1234973
- ChEMBL:CHEMBL1331216
- ChEMBL:CHEMBL2449003
- EPA DTXSID:DTXSID20941522
- EPA DTXSID:DTXSID80889335
- PubMed:22967766
- PubMed:22955966
- PubMed:22705021
- PubMed:22655106
- PubMed:22546652
- PubMed:22486036
- PubMed:22461927
- PubMed:22438667
- PubMed:22391493
- PubMed:22305072
- PubMed:22299130
- PubMed:22220140
Evidence from additional scientific databases
EMBL-EBI ChEBI
(S)-atropine
An atropine with a 2S-configuration.
- Formula
- C17H23NO3
- Average mass
- 289.375 g/mol
- Monoisotopic mass
- 289.16779 Da
- Formal charge
- 0
- tropan-3α-yl 3-hydroxy-2-phenylpropanoate — is a (CHEBI:78734)
- (S)-tropic acid — has functional parent (CHEBI:30766)
- tropan-3α-yl 3-hydroxy-2-phenylpropanoate — is a (CHEBI:78734)
- (S)-atropinium — is conjugate base of (CHEBI:58164)
Additional curated names
Cross-references from this source
- CAS: 101-31-5 — KEGG COMPOUND
- CAS: 101-31-5 — ChemIDplus
- CAS: 101-31-5 — NIST Chemistry WebBook
- MANUAL_X_REF: 1402 — DrugCentral
- MANUAL_X_REF: C00002293 — KNApSAcK
- MANUAL_X_REF: C02046 — KEGG COMPOUND
- MANUAL_X_REF: D00147 — KEGG DRUG
- MANUAL_X_REF: DB00424 — DrugBank
- MANUAL_X_REF: OIN — PDBeChem
- REGISTRY_NUMBER: 91259 — Reaxys
Mapped by: Exact CAS cross-reference in the ChEBI compound record. Source updated: 2017-02-22. Retrieved: 2026-08-31. Open source record
NIH PubChem PUG-View
Attributed physical-property, hazard, environmental and use annotations.
Mapped by: Existing checksum-valid CAS to unique PubChem CID match. Retrieved: 2026-08-31. Open source record
Scientific classifications and hazard annotations provide context and do not replace the market-specific regulatory decision shown above.
Additional source coverage and match status
| Source | Result | Checked |
|---|---|---|
| EMBL-EBI ChEBI | Exact match | 2026-08-31 |
| NIH PubChem PUG-View | Exact match | 2026-08-31 |
A recorded no-match is useful evidence that the source was checked; it is not a claim that the substance does not exist elsewhere.
Retrieved from NIH PubChem on 2026-08-31 by checksum-valid CAS matching. Chemical properties do not replace the regulatory decision on this page.
Record details
Chemical name
Hyoscyamine, its salts and derivatives
Chemical / IUPAC name
Benzeneacetic acid, alpha-(hydroxymethyl)-, (3-endo)-8-methyl-8-azabicyclo(3.2.1)oct-3-yl ester, (alphaS)-
Regulatory information
Key data
Related records for Hyoscyamine, its salts and derivatives
Direct matches are limited for this record, so nearby entries from Annex II are shown as well.
Nitroxoline (INN) and its salts
Hyoscyamus niger L. (leaves, seeds, powder and galenical preparations)
Pemoline (INN) and its salts
4,4'-Dihydroxy-3,3'-(3-methylthiopropylidene) dicoumarin
Decamethylenebis(trimethylammonium) salts, e.g. decamethonium bromide (INN)
Ipecacuanha (Cephaelis ipecacuanha Brot. and related species) (roots, powder and galenical preparat…
Ethyl bis(4-hydroxy-2-oxo-1-benzopyran-3-yl)acetate and salts of the acid
(2-Isopropylpent-4-enoyl)urea (apronalide)
What Annex II means for Hyoscyamine, its salts and derivatives
Hyoscyamine, its salts and derivatives is listed as a prohibited substance under Annex II of EU Cosmetics Regulation 1223/2009 and must not be intentionally added. Article 17 separately addresses unintended small quantities that are technically unavoidable under good manufacturing practice and compatible with the Article 3 safety requirement.
Formulators must screen their ingredients and raw materials to ensure none contain this substance. Suppliers should provide documentation confirming absence when requested.
The page also surfaces 12 related annex records with overlapping identifiers, annex logic or naming patterns.
Compliance checklist
- Verify this substance is absent from all raw materials and finished formulations.
- Request absence confirmation or CoA from raw material suppliers.
- Document the screening result in the Product Information File (PIF).
Frequently asked questions
Source note for Annex II record Hyoscyamine, its salts and derivatives
This page summarizes one Annex II record for Hyoscyamine, its salts and derivatives from public European Commission cosmetic materials and adds linked inventory or identifier matches when available.
Use this record page to review Annex II conditions for Hyoscyamine, its salts and derivatives, but confirm any final regulatory decision against the current official annex wording and source files.
Tools & next steps
Check your formula
Paste a full INCI list to detect Hyoscyamine, its salts and derivatives and other flagged EU annex records in one pass.
INCI CheckerCompare entries
Compare Hyoscyamine, its salts and derivatives side by side with another annex record to review differences in restrictions, concentrations and annex placement.
CompareBrowse the annex
See all records in Annex II and compare regulatory conditions across substances in this annex.
Open Annex II